Rosavin exerts an antitumor role and inactivates the MAPK/ERK pathway in small-cell lung carcinoma in vitro
, , , e
12 giu 2023
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 12 giu 2023
Pagine: 269 - 280
Accettato: 03 dic 2022
DOI: https://doi.org/10.2478/acph-2023-0015
Parole chiave
© 2023 Rui Liu et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Liu, Rui
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Jiang, Cuihong
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Zhao, Zhizheng
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Lv, Yutong
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China
Wang, Gaoxing
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences (South Campus)Beijing, China